TTD | Drug: D0A9ML

Drug General Information
Drug ID	D0A9ML
Former ID	DCL001239
Drug Name	SelG1
Drug Type	Antibody
Indication	Vaso-occlusive crisis [ICD9: 282.62; ICD10:D57.00]		Phase 1	[551678]
Company	Selexys Pharmaceuticals
Target and Pathway
Target(s)	P-selectin	Target Info		[551678]
KEGG Pathway	Cell adhesion molecules (CAMs)
	Malaria
	Staphylococcus aureus infection
Pathway Interaction Database	IL4-mediated signaling events
Pathway Interaction Database	amb2 Integrin signaling
Reactome	Platelet degranulation
Reactome	Cell surface interactions at the vascular wall
WikiPathways	Human Complement System
	Spinal Cord Injury
	Cell surface interactions at the vascular wall
References
Ref 551678	Clinical pipeline report, company report or official report of Selexys Pharmaceuticals (2011).
Ref 551678	Clinical pipeline report, company report or official report of Selexys Pharmaceuticals (2011).

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.

Drug Information